USPSTF: Evidence lacking for nontraditional CVD risk factors

January 17, 2018

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that current evidence is insufficient to assess the use of nontraditional risk factors for cardiovascular disease (CVD) risk assessment. They also conclude that evidence is lacking for the use of the ankle-brachial index (ABI) to screen for peripheral arterial disease (PAD) in asymptomatic individuals. These findings form the basis of two draft recommendation statements published online Jan. 16 by the USPSTF.

Jennifer S. Lin, M.D., from the Kaiser Permanente Center for Health Research in Portland, Ore., and colleagues reviewed use of ABI, high-sensitivity C-reactive protein, and score in asymptomatic adults. The authors found that there was adequate evidence for the benefit of adding these factors to existing CVD models; however, the evidence was inadequate for assessing treatment decision-making guided by these scores. Based on these findings, the USPSTF concluded that the current evidence is insufficient to assess the balance of harms and benefits of adding these scores to traditional risk assessment.

Janelle M. Guirguis-Blake, M.D., also from the Kaiser Permanente Center for Health Research, and colleagues conducted a systematic review relating to ABI screening for PAD and CVD. The researchers found that ABI is an accurate test for detecting PAD in symptomatic patients, but few data were available on the accuracy of ABI for identifying who could benefit from treatment. Based on these findings, the USPSTF concluded that the current evidence is insufficient for assessing the balance of benefits and harms associated with PAD and CVD risk screening with ABI.

These findings form the basis of two draft recommendation statements, which are available for public comment from Jan. 16 through Feb. 12, 2018.

Explore further: USPSTF reviews use of ECG for preventing A-fib, CVD events

More information: Evidence Review - CVD
Draft Recommendation Statement - CVD
Comment on Recommendation Statement - CVD
Evidence Review - PAD
Draft Recommendation Statement - PAD
Comment on Recommendation Statement - PAD

Related Stories

USPSTF reviews use of ECG for preventing A-fib, CVD events

December 19, 2017
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found that the current evidence is inadequate to assess the benefits and harms of screening with electrocardiogram (ECG) for atrial fibrillation (AF) in older ...

USPSTF: evidence lacking for pelvic screening examinations

June 29, 2016
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to weigh the balance of benefits and harms for screening pelvic examinations in asymptomatic, nonpregnant ...

USPSTF draft recommendation urges against COPD screening

August 18, 2015
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found no net benefit for chronic obstructive pulmonary disease (COPD) screening in asymptomatic adults and consequently recommends against screening. These ...

USPSTF finds evidence lacking for autism screening in children

August 4, 2015
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that there is currently insufficient evidence to assess the benefits and harms of screening for autism spectrum disorder (ASD) in asymptomatic children ...

Evidence insufficient to screen for celiac disease

March 28, 2017
The U.S. Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons. The report appears ...

USPSTF finds evidence lacking for sleep apnea screening

June 15, 2016
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found insufficient evidence for the benefit of obstructive sleep apnea (OSA) screening in asymptomatic populations. These findings form the basis of a draft ...

Recommended for you

Non-coding genetic variant could improve key vascular functions

November 15, 2018
Atherosclerotic disease, the slow and silent hardening and narrowing of the arteries, is a leading cause of mortality worldwide. It is responsible for more than 15 million deaths each year, including an estimated 610,000 ...

Study of two tribes sheds light on role of Western-influenced diet in blood pressure

November 14, 2018
A South American tribe living in near-total isolation with no Western dietary influences showed no increase in average blood pressure from age one to age 60, according to a study led by researchers at Johns Hopkins Bloomberg ...

Heart failure patients shouldn't stop meds even if condition improves: study

November 13, 2018
(HealthDay)—There's bad news for heart failure patients with dilated cardiomyopathy who'd like to stop taking their meds.

Bypass beats stents for diabetics with heart trouble: study

November 13, 2018
(HealthDay)—People with both diabetes and multiple clogged heart arteries live longer if they undergo bypass surgery rather than have their blood vessels reopened with stents, according to follow-up results from a landmark ...

Kawasaki disease: One disease, multiple triggers

November 12, 2018
Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography, and international collaborators have evidence that Kawasaki Disease (KD) does not have a single cause. By studying ...

New treatment significantly reduces cardiovascular events when combined with statins

November 12, 2018
Statins are the most commonly used treatment for cardiovascular disease. Despite reducing certain risk factors, if triglyceride levels remain high with use of statins, there is still a significant risk for heart attack, stroke ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.